MYCR Mycronic AB (publ)
Mycronic AB (publ) develops, manufactures, and sells production equipment for electronics industry in Sweden, rest of Europe, the United States, other Americas, China, South Korea, rest of Asia, and internationally. It operates through four segments: Pattern Generators, PCB Assembly, High-Volume, and Global Technologies. The Pattern Generators segment develops, manufactures, and markets mask writers and metrology systems for display manufacturing and production of semiconductors. The PCB Assembly segment develops, manufactures, and markets flexible PCB assembly solutions, including jet printing, stencil printing, 3D inspection, component placement, and automated storage solutions. The High-Volume segment develops, manufactures, and markets automated system for dispensing and conformal coating for high-volume electronics production. The Global Technologies segment offers die bonding, PCB test, photonic interconnects, magnetic test, and applied plasma. The company sells its products through agents and distributors. It serves aerospace, defense, medical, and industrial electronics sectors. The company was formerly known as Micronic Mydata AB (publ) and changed its name to Mycronic AB (publ) in June 2014. Mycronic AB (publ) was incorporated in 1989 and is headquartered in Täby, Sweden.…
Industry Peers
Specialty Industrial MachineryKey Statistics
About Mycronic (STO: MYCR)
›
Mycronic (STO: MYCR) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Specialty Industrial Machinery industry, part of the Industrials sector, and reports about 2,875 employees.
The shares were at 301.60 SEK on 19 November 2026, up 41.8% over 52 weeks. Its 52-week range is 183.32 SEK to 364.40 SEK: the price is 17.2% below the high and 64.5% above the low.
At a market capitalisation of 58.90B SEK, it trades at 29.6 times trailing earnings and 18.4 times forward earnings. The median trailing P/E of its 20 largest Specialty Industrial Machinery peers is 29.0, so MYCR is valued in line with them. It pays a dividend yielding 1.09% (it pays out 32% of its earnings), against a median of 1.69% among the dividend payers in that peer group.
Mycronic reports return on equity of 21.9%, an operating margin of 29.4% and revenue up 37.9% year over year.
It holds more cash than debt, a net cash position of 2.86B SEK. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 4 analysts cover the stock, with an average rating of Buy; their mean price target of 325.50 SEK is 7.9% above the current price. The next earnings report is expected on 4 February 2027.